16-fluoro-5-androsten-17-one has been researched along with Alloxan Diabetes in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pashko, LL; Schwartz, AG | 1 |
1 other study(ies) available for 16-fluoro-5-androsten-17-one and Alloxan Diabetes
Article | Year |
---|---|
Antihyperglycemic effect of dehydroepiandrosterone analogue 16 alpha-fluoro-5-androsten-17-one in diabetic mice.
Topics: Androstenes; Animals; Dehydroepiandrosterone; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Organ Size; Seminal Vesicles; Testosterone | 1993 |